메뉴 건너뛰기
Cancer Treatment Reviews
Volumn 32, Issue SUPPL. 1, 2006, Pages 1-2
The role of bone markers in metastatic bone disease
Author keywords

Bone markers; Bone metastases; Metastatic bone disease
Indexed keywords

BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE;
EID: 33646235165     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(06)80001-0     Document Type: Article
Times cited : (10)
References (9)
  • 1
    • 12444343707 scopus 로고    scopus 로고
    • Bone metastases
    • Abeloff M., Armitage J., Niederhuber J., Kastan M., and McKenna W. (Eds), Churchill Livingstone, New York
    • Coleman R., and Rubens R. Bone metastases. In: Abeloff M., Armitage J., Niederhuber J., Kastan M., and McKenna W. (Eds). Clinical Oncology. 2nd edn. (2004), Churchill Livingstone, New York 1091
    • (2004) Clinical Oncology. 2nd edn. , pp. 1091
    • Coleman, R.1    Rubens, R.2
  • 2
    • 0037093808 scopus 로고    scopus 로고
    • The clinical use of bone resorption markers in patients with malignant bone disease
    • Coleman R. The clinical use of bone resorption markers in patients with malignant bone disease. Cancer 94 (2002) 2521-2533
    • (2002) Cancer , vol.94 , pp. 2521-2533
    • Coleman, R.1
  • 3
    • 0036675220 scopus 로고    scopus 로고
    • Metastasis to bone: causes, consequences and therapeutic opportunities
    • Mundy G. Metastasis to bone: causes, consequences and therapeutic opportunities. Natl Rev Cancer 2 (2002) 584-593
    • (2002) Natl Rev Cancer , vol.2 , pp. 584-593
    • Mundy, G.1
  • 4
    • 32944481493 scopus 로고    scopus 로고
    • Gonadotropin-releasing hormone agonists and fracture risk: a daims-based cohort study of men with nonmetastatic prostate cancer
    • Smith M., Lee W., Brandman J., et al. Gonadotropin-releasing hormone agonists and fracture risk: a daims-based cohort study of men with nonmetastatic prostate cancer. J Clin Oncol 23 (2005) 7897-7903
    • (2005) J Clin Oncol , vol.23 , pp. 7897-7903
    • Smith, M.1    Lee, W.2    Brandman, J.3
  • 5
    • 11844252588 scopus 로고    scopus 로고
    • Risk of fracture after androgen deprivation for prostate cancer
    • Shahinian V., Kuo Y., Freeman J., et al. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 352 (2005) 154-164
    • (2005) N Engl J Med , vol.352 , pp. 154-164
    • Shahinian, V.1    Kuo, Y.2    Freeman, J.3
  • 6
    • 0035004937 scopus 로고    scopus 로고
    • Biochemical markers of bone disease in asymptomatic early stage multiple myeloma: a study on their role in identifying high risk patients
    • Corso A., Arcaini L., Arcaini L., Mangiacavalli S., et al. Biochemical markers of bone disease in asymptomatic early stage multiple myeloma: a study on their role in identifying high risk patients. Haematologica 86 (2001) 394-398
    • (2001) Haematologica , vol.86 , pp. 394-398
    • Corso, A.1    Arcaini, L.2    Arcaini, L.3    Mangiacavalli, S.4
  • 7
    • 2942518111 scopus 로고    scopus 로고
    • Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer
    • Zoledronic Acid Prostate Cancer Study Group
    • Saad F., Gleason D., Murray R., et al., Zoledronic Acid Prostate Cancer Study Group. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 96 (2004) 879-882
    • (2004) J Natl Cancer Inst , vol.96 , pp. 879-882
    • Saad, F.1    Gleason, D.2    Murray, R.3
  • 8
    • 0043245842 scopus 로고    scopus 로고
    • Soluble receptor activator of nuclear factor kβ ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index
    • Terpos E., Szydlo R., Appertey J., et al. Soluble receptor activator of nuclear factor kβ ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. Blood 102 (2003) 1064-1069
    • (2003) Blood , vol.102 , pp. 1064-1069
    • Terpos, E.1    Szydlo, R.2    Appertey, J.3
  • 9
    • 24644440599 scopus 로고    scopus 로고
    • High bone turnover markers predict poor outcome in patients with bone metastasis
    • Roodman G. High bone turnover markers predict poor outcome in patients with bone metastasis. J Clin Oncol 23 (2005) 4821-4822
    • (2005) J Clin Oncol , vol.23 , pp. 4821-4822
    • Roodman, G.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.